首页 > 最新文献

Israel Journal of Health Policy Research最新文献

英文 中文
Public conformism with health regulation is crumbling as COVID-19 becomes a chronic threat: Repeated Cross-sectional Studies. 随着COVID-19成为一种慢性威胁,公众对卫生监管的顺从正在崩溃:重复横断面研究
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-02-03 DOI: 10.1186/s13584-023-00555-y
Moran Bodas, Leora Wine, Kobi Peleg

Background: The purpose of this study is to analyze the long terms trends in public attitudes toward the COVID-19 pandemic and compliance with self-quarantine regulations.

Methods: Repeated cross-sectional studies looking into data collected from nationally representative samples (N = 2568) of the adult population in Israel at five points in time representing the five morbidity waves of the COVID-19 pandemic. This study examined public trust in Israeli health regulations, levels of public panic, feelings of personal worry, and compliance with health regulations, specifically self-quarantine.

Results: Public trust in health regulations in January 2022 is at an all-time low (25%) compared to the maximum value of nearly 75% measured in March 2020. While reported worry is steadily reducing, the perception of public panic is increasing. In earlier rounds, public compliance with self-quarantine was reported close to 100%; however, it has dropped to 38% by January 2022 when compensation is not assumed. Regression analysis suggests that trust is a major predictor of compliance with health regulations.

Conclusions: The "fifth wave" of the COVID-19 pandemic brought about an all-time low in public trust in health regulations. The Israeli public, normally a highly compliant one, is showing signs of crumbling conformity.

背景:本研究的目的是分析公众对COVID-19大流行的态度和遵守自我隔离规定的长期趋势。方法:重复横断面研究,研究在代表COVID-19大流行的五个发病波的五个时间点从以色列成年人口的全国代表性样本(N = 2568)收集的数据。这项研究调查了公众对以色列卫生法规的信任程度、公众恐慌程度、个人担忧程度以及对卫生法规的遵守情况,特别是自我隔离。结果:与2020年3月测得的近75%的最高值相比,2022年1月公众对卫生法规的信任度处于历史最低点(25%)。虽然报道的担忧正在稳步减少,但公众恐慌的感觉却在增加。据报道,在前几轮中,公众遵守自我隔离的比例接近100%;然而,到2022年1月,当不考虑补偿时,这一比例已降至38%。回归分析表明,信任是遵守卫生法规的主要预测因素。结论:“第五波”疫情导致公众对卫生法规的信任度降至历史最低点。以色列公众,通常是高度顺从的,正在显示出顺从的崩溃迹象。
{"title":"Public conformism with health regulation is crumbling as COVID-19 becomes a chronic threat: Repeated Cross-sectional Studies.","authors":"Moran Bodas,&nbsp;Leora Wine,&nbsp;Kobi Peleg","doi":"10.1186/s13584-023-00555-y","DOIUrl":"https://doi.org/10.1186/s13584-023-00555-y","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study is to analyze the long terms trends in public attitudes toward the COVID-19 pandemic and compliance with self-quarantine regulations.</p><p><strong>Methods: </strong>Repeated cross-sectional studies looking into data collected from nationally representative samples (N = 2568) of the adult population in Israel at five points in time representing the five morbidity waves of the COVID-19 pandemic. This study examined public trust in Israeli health regulations, levels of public panic, feelings of personal worry, and compliance with health regulations, specifically self-quarantine.</p><p><strong>Results: </strong>Public trust in health regulations in January 2022 is at an all-time low (25%) compared to the maximum value of nearly 75% measured in March 2020. While reported worry is steadily reducing, the perception of public panic is increasing. In earlier rounds, public compliance with self-quarantine was reported close to 100%; however, it has dropped to 38% by January 2022 when compensation is not assumed. Regression analysis suggests that trust is a major predictor of compliance with health regulations.</p><p><strong>Conclusions: </strong>The \"fifth wave\" of the COVID-19 pandemic brought about an all-time low in public trust in health regulations. The Israeli public, normally a highly compliant one, is showing signs of crumbling conformity.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"12 1","pages":"7"},"PeriodicalIF":4.5,"publicationDate":"2023-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9842767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of biostatistics in the response to COVID-19: a Belgian and international perspective. 生物统计学在应对COVID-19中的作用:比利时和国际视角。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-01-31 DOI: 10.1186/s13584-023-00554-z
Geert Molenberghs

In this commentary to Dattner et al. (Israel J Health Policy Res. 11:22, 2022), we highlight similarities and differences in the role that biostatistics and biostatisticians have been playing in the COVID-19 response in Belgium and Israel. We bring out implications and opportunities for our field and for science. We argue that biostatistics has an important place in the multidisciplinary COVID-19 response, in terms of research, policy advice, and science and public communication. In Belgium, biostatisticians located in various institutes, collaborated with epidemiologists, vaccinologists, infectiologists, immunologists, social scientists, and government policy makers to provide rapid and science-informed policy advice. Biostatisticians, who can easily be mobilized to work together in pandemic response, also played a role in public communication.

在这篇对Dattner等人的评论中(Israel J Health Policy rs . 11:22, 2022),我们强调了生物统计学和生物统计学家在比利时和以色列应对COVID-19中所发挥作用的异同。我们为我们的领域和科学带来了启示和机会。我们认为,在研究、政策咨询、科学和公众传播方面,生物统计学在多学科COVID-19应对工作中发挥着重要作用。在比利时,分布在各个研究所的生物统计学家与流行病学家、疫苗学家、传染病学家、免疫学家、社会科学家和政府决策者合作,提供快速和科学的政策建议。生物统计学家很容易被动员起来共同应对大流行,他们也在公共沟通中发挥了作用。
{"title":"The role of biostatistics in the response to COVID-19: a Belgian and international perspective.","authors":"Geert Molenberghs","doi":"10.1186/s13584-023-00554-z","DOIUrl":"https://doi.org/10.1186/s13584-023-00554-z","url":null,"abstract":"<p><p>In this commentary to Dattner et al. (Israel J Health Policy Res. 11:22, 2022), we highlight similarities and differences in the role that biostatistics and biostatisticians have been playing in the COVID-19 response in Belgium and Israel. We bring out implications and opportunities for our field and for science. We argue that biostatistics has an important place in the multidisciplinary COVID-19 response, in terms of research, policy advice, and science and public communication. In Belgium, biostatisticians located in various institutes, collaborated with epidemiologists, vaccinologists, infectiologists, immunologists, social scientists, and government policy makers to provide rapid and science-informed policy advice. Biostatisticians, who can easily be mobilized to work together in pandemic response, also played a role in public communication.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"12 1","pages":"6"},"PeriodicalIF":4.5,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9842759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Timing, extent and outcomes of public health measures in the first wave of the COVID-19 pandemic in Israel and a comparative analysis by socioeconomic indices. 以色列第一波COVID-19大流行中公共卫生措施的时间、范围和结果以及社会经济指标的比较分析
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-01-30 DOI: 10.1186/s13584-022-00549-2
Amit Ginzburg, Deborah Barasche-Berdah, Orly Manor, Ronit Levine-Schnur, Ora Paltiel, Hagai Levine

Background: Early in the coronavirus disease 2019 (COVID-19) pandemic, governments implemented exceptional public health measures (PHMs) in the face of uncertainty. This study aimed to compare mitigation policies implemented by Israel and their timing in the first wave of the pandemic to those of other countries, and to assess whether country characteristics such as democracy, trust, education, economic strength and healthcare reserve were associated with decision-making.

Methods: PHMs and pre-pandemic characteristics, using internationally accepted indices, of 50 countries were collected from 1/1/2020-30/06/2020; and associations between them were assessed. Time to implementation of these measures was compared among the Organisation for Economic Co-operation (OECD) nations. Log-rank test was used for univariate analysis. Cox regression was performed to assess the independent contribution of pre-pandemic characteristics to time-to-implementation of measures. Correlations between timing of specific measures and COVID-19 mortality at 60 days were assessed.

Results: Israel ranked in the upper third of the OECD in swiftness to implementation of eight of the ten measures compared. In univariate survival analysis, countries with an education level below the OECD median were more likely to implement a lockdown (p-value = 0.043) and to close restaurants and entertainment venues (p-value = 0.007) when compared to countries above the OECD median. In Cox regression models, controlling for geographic location, democracy level above the OECD median was associated with a longer time-to-implementation of a lockdown (HR=0.35, 95% CI=0.14-0.88, p-value=0.025). Similarly, a high level of GDP per capita was inversely associated with closing schools; and a high level of education inversely associated with closure of restaurants and entertainment venues. Earlier initiation of all PHMs was associated with lower mortality at 60 days, controlling for geographic location.

Conclusions: Israel's initial response to the pandemic was relatively quick, and may have been facilitated by its geographic isolation. Countries with lower pre-pandemic socio-economic indices were quicker to initiate forced social distancing. Early initiation of PHMs was associated with reduced mortality in the short run. Timing of initiation of measures relative to the country-specific spread of disease is a significant factor contributing to short-term early local pandemic control, perhaps more than the exact measures implemented. It is important to note that this study is limited to the initial pandemic response. Furthermore, it does not take into account the broader long-term effects of certain PHMs, which should be a focus of further research.

背景:在2019冠状病毒病(COVID-19)大流行早期,各国政府在面临不确定性时实施了特殊的公共卫生措施。本研究旨在比较以色列实施的缓解政策及其在第一波大流行中与其他国家实施的缓解政策的时机,并评估民主、信任、教育、经济实力和医疗储备等国家特征是否与决策相关。方法:采用国际通行的指标,于2020年1月1日~ 2020年6月30日采集50个国家的phm和流行前特征;并评估了它们之间的联系。对经济合作组织(OECD)成员国实施这些措施的时间进行了比较。单因素分析采用Log-rank检验。采用Cox回归来评估大流行前特征对措施实施时间的独立贡献。评估特定措施的时间与60天COVID-19死亡率之间的相关性。结果:以色列在实施10项措施中的8项的速度上排名经合组织的前三分之一。在单变量生存分析中,与经合组织中位数以上的国家相比,教育水平低于经合组织中位数的国家更有可能实施封锁(p值= 0.043),并关闭餐馆和娱乐场所(p值= 0.007)。在Cox回归模型中,控制地理位置,高于经合组织中位数的民主水平与实施封锁的时间较长相关(HR=0.35, 95% CI=0.14-0.88, p值=0.025)。同样,高水平的人均GDP与关闭学校呈负相关;高教育水平与餐馆和娱乐场所的关闭呈负相关。在控制地理位置的情况下,早期开始所有phm与60天内较低的死亡率相关。结论:以色列对这一流行病的最初反应相对较快,这可能是由于其地理位置的孤立而促成的。大流行前社会经济指数较低的国家更快地开始强制保持社会距离。早期开始PHMs与短期死亡率降低有关。针对特定国家的疾病传播采取措施的时机,是有助于短期及早控制当地大流行病的一个重要因素,也许比所实施的确切措施更重要。值得注意的是,这项研究仅限于最初的大流行应对。此外,它没有考虑到某些PHMs更广泛的长期影响,这应该是进一步研究的重点。
{"title":"Timing, extent and outcomes of public health measures in the first wave of the COVID-19 pandemic in Israel and a comparative analysis by socioeconomic indices.","authors":"Amit Ginzburg,&nbsp;Deborah Barasche-Berdah,&nbsp;Orly Manor,&nbsp;Ronit Levine-Schnur,&nbsp;Ora Paltiel,&nbsp;Hagai Levine","doi":"10.1186/s13584-022-00549-2","DOIUrl":"https://doi.org/10.1186/s13584-022-00549-2","url":null,"abstract":"<p><strong>Background: </strong>Early in the coronavirus disease 2019 (COVID-19) pandemic, governments implemented exceptional public health measures (PHMs) in the face of uncertainty. This study aimed to compare mitigation policies implemented by Israel and their timing in the first wave of the pandemic to those of other countries, and to assess whether country characteristics such as democracy, trust, education, economic strength and healthcare reserve were associated with decision-making.</p><p><strong>Methods: </strong>PHMs and pre-pandemic characteristics, using internationally accepted indices, of 50 countries were collected from 1/1/2020-30/06/2020; and associations between them were assessed. Time to implementation of these measures was compared among the Organisation for Economic Co-operation (OECD) nations. Log-rank test was used for univariate analysis. Cox regression was performed to assess the independent contribution of pre-pandemic characteristics to time-to-implementation of measures. Correlations between timing of specific measures and COVID-19 mortality at 60 days were assessed.</p><p><strong>Results: </strong>Israel ranked in the upper third of the OECD in swiftness to implementation of eight of the ten measures compared. In univariate survival analysis, countries with an education level below the OECD median were more likely to implement a lockdown (p-value = 0.043) and to close restaurants and entertainment venues (p-value = 0.007) when compared to countries above the OECD median. In Cox regression models, controlling for geographic location, democracy level above the OECD median was associated with a longer time-to-implementation of a lockdown (HR=0.35, 95% CI=0.14-0.88, p-value=0.025). Similarly, a high level of GDP per capita was inversely associated with closing schools; and a high level of education inversely associated with closure of restaurants and entertainment venues. Earlier initiation of all PHMs was associated with lower mortality at 60 days, controlling for geographic location.</p><p><strong>Conclusions: </strong>Israel's initial response to the pandemic was relatively quick, and may have been facilitated by its geographic isolation. Countries with lower pre-pandemic socio-economic indices were quicker to initiate forced social distancing. Early initiation of PHMs was associated with reduced mortality in the short run. Timing of initiation of measures relative to the country-specific spread of disease is a significant factor contributing to short-term early local pandemic control, perhaps more than the exact measures implemented. It is important to note that this study is limited to the initial pandemic response. Furthermore, it does not take into account the broader long-term effects of certain PHMs, which should be a focus of further research.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"12 1","pages":"5"},"PeriodicalIF":4.5,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9465469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of implementation of mental health services within primary care on GP detection and treatment of mental disorders in Israel. 在以色列初级保健中实施精神卫生服务对全科医生发现和治疗精神障碍的影响。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-01-30 DOI: 10.1186/s13584-023-00553-0
Neil Laufer, Nelly Zilber, Pablo Jeczmien, Royi Gilad, Shai Gur, Hanan Munitz

Background: Psychiatric morbidity is frequent in primary care, but a substantial proportion of these psychiatric problems appear to be neither recognized nor adequately treated by GPs. There exists a number of models of introduction of mental health services (MHS) into primary care, but little data are available on their effect on GPs' detection or management of mental disorders. The study aimed to measure the effect of referring patients to a psychiatrist within primary care (Shifted OutPatient model-SOP) or consultation of psychiatrists by the GPs (Psychiatric Community Consultation Liaison-PCCL) on the detection and treatment of mental disorders by GPs.

Methods: In six primary care clinics in Israel (three "SOP clinics" and three "PCCL clinics"), GP detection of mental disorders and treatment of GP-detected cases were evaluated before and after provision of 1-year MHS, according to GP questionnaires on a sample of primary care consecutive attenders whose psychological distress was determined according to the GHQ12 and psychiatric disorders according to the Composite International Diagnostic Interview.

Results: After model implementation, a significant reduction in detection of mental disorders was found in SOP clinics, while no significant change was found in PCCL clinics. No significant change in detection of distress was found in any clinic. An increase in referrals to MHS for GP-diagnosed depression and anxiety cases, a reduction in GP counselling for GP-detected cases and those with diagnosed anxiety, an increased prescription of antidepressants and a reduced prescription of antipsychotics were found in SOP clinics. In PCCL clinics, no significant changes in GP management were observed except an increase in referral of GP-diagnosed depression cases to MHS.

Conclusions: MHS models did not improve GP detection of mental disorders or distress, but possibly improved referral case mix. The SOP model might have a deskilling influence on GPs, resulting from less involvement in treatment, with decrease of detection and counselling. This should be taken into consideration when planning to increase referrals to a psychiatrist within primary care settings. Lack of positive effect of the PCCL model might be overcome by more intensive programs incorporating educational components.

背景:精神疾病在初级保健中很常见,但这些精神问题的很大一部分似乎既没有被全科医生认识到,也没有得到充分的治疗。在初级保健中引入精神卫生服务(MHS)的模式有很多,但关于它们对全科医生检测或管理精神障碍的影响的数据很少。本研究旨在衡量在初级保健(转移门诊模式- sop)或全科医生咨询精神科医生(精神病学社区咨询联络- pccl)中转诊患者对全科医生发现和治疗精神障碍的影响。方法:在以色列的6家初级保健诊所(3家“SOP诊所”和3家“PCCL诊所”),根据GP对根据GHQ12确定心理困扰的初级保健连续就诊者样本进行问卷调查,并根据综合国际诊断访谈确定精神障碍,评估GP在提供1年MHS前后对精神障碍的检测和治疗。结果:模型实施后,SOP诊所的精神障碍检出率显著降低,而PCCL诊所的精神障碍检出率无显著变化。在任何诊所中,对痛苦的检测都没有发现明显的变化。在SOP诊所发现,GP诊断的抑郁和焦虑病例转介到MHS的人数增加,GP检测病例和诊断为焦虑的患者的全科医生咨询减少,抗抑郁药处方增加,抗精神病药处方减少。在PCCL诊所,除了GP诊断的抑郁症病例转介到MHS的增加外,GP管理没有明显变化。结论:MHS模型并没有提高全科医生对精神障碍或痛苦的检测,但可能改善了转诊病例组合。SOP模式可能会对全科医生产生去技能化的影响,导致较少参与治疗,减少检测和咨询。在计划增加初级保健机构的精神病医生转诊时,应考虑到这一点。PCCL模式缺乏积极的影响,可以通过更密集的项目纳入教育成分来克服。
{"title":"Effect of implementation of mental health services within primary care on GP detection and treatment of mental disorders in Israel.","authors":"Neil Laufer,&nbsp;Nelly Zilber,&nbsp;Pablo Jeczmien,&nbsp;Royi Gilad,&nbsp;Shai Gur,&nbsp;Hanan Munitz","doi":"10.1186/s13584-023-00553-0","DOIUrl":"https://doi.org/10.1186/s13584-023-00553-0","url":null,"abstract":"<p><strong>Background: </strong>Psychiatric morbidity is frequent in primary care, but a substantial proportion of these psychiatric problems appear to be neither recognized nor adequately treated by GPs. There exists a number of models of introduction of mental health services (MHS) into primary care, but little data are available on their effect on GPs' detection or management of mental disorders. The study aimed to measure the effect of referring patients to a psychiatrist within primary care (Shifted OutPatient model-SOP) or consultation of psychiatrists by the GPs (Psychiatric Community Consultation Liaison-PCCL) on the detection and treatment of mental disorders by GPs.</p><p><strong>Methods: </strong>In six primary care clinics in Israel (three \"SOP clinics\" and three \"PCCL clinics\"), GP detection of mental disorders and treatment of GP-detected cases were evaluated before and after provision of 1-year MHS, according to GP questionnaires on a sample of primary care consecutive attenders whose psychological distress was determined according to the GHQ12 and psychiatric disorders according to the Composite International Diagnostic Interview.</p><p><strong>Results: </strong>After model implementation, a significant reduction in detection of mental disorders was found in SOP clinics, while no significant change was found in PCCL clinics. No significant change in detection of distress was found in any clinic. An increase in referrals to MHS for GP-diagnosed depression and anxiety cases, a reduction in GP counselling for GP-detected cases and those with diagnosed anxiety, an increased prescription of antidepressants and a reduced prescription of antipsychotics were found in SOP clinics. In PCCL clinics, no significant changes in GP management were observed except an increase in referral of GP-diagnosed depression cases to MHS.</p><p><strong>Conclusions: </strong>MHS models did not improve GP detection of mental disorders or distress, but possibly improved referral case mix. The SOP model might have a deskilling influence on GPs, resulting from less involvement in treatment, with decrease of detection and counselling. This should be taken into consideration when planning to increase referrals to a psychiatrist within primary care settings. Lack of positive effect of the PCCL model might be overcome by more intensive programs incorporating educational components.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"12 1","pages":"4"},"PeriodicalIF":4.5,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9465467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes and trends in medication-assisted treatment in Israel. 以色列药物辅助治疗的变化和趋势。
IF 3.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-01-26 DOI: 10.1186/s13584-022-00551-8
Adi Marom, Iris Levy, Paola Rosca

Background: As opioid prescription in Israel is increasing, there is a growing need for monitoring opioid use disorder and providing opioid agonist therapy. Our goal is to describe, sub-analyze, and identify obstacles in the treatment of opioid misuse in the Israeli medication assisted treatment centers.

Methods: Data on methadone, buprenorphine, and buprenorphine combined with naloxone for the indication of opioid addiction treatment for the period 2013-2020 were obtained from pharmaceutical companies that distribute them in Israel. Data on utilization of these drugs were also extracted from the database maintained by the Israel Ministry of Health's Pharmaceutical Administration Division. The data were converted to defined daily doses (DDD)/1000 inhabitants/day.

Results: The number of patients receiving medication assisted treatment increased by 10% since 2013, with a shift from buprenorphine alone to buprenorphine/naloxone in government-run centers. Methadone remains the most popular maintenance drug.

Conclusions: The change in opioid maintenance prescription does not match the significant increase in opioid consumption. Optimization of treatment can be achieved by the creation of a comprehensive database, cooperation between healthcare organizations and the government and further development of non-stigmatic and accessible services.

背景:随着以色列阿片类药物处方量的不断增加,监测阿片类药物使用障碍和提供阿片类药物激动剂治疗的需求也在不断增长。我们的目标是对以色列药物辅助治疗中心在治疗阿片类药物滥用方面的障碍进行描述、子分析和识别:从在以色列经销美沙酮、丁丙诺啡和丁丙诺啡联合纳洛酮的制药公司获得了 2013-2020 年期间用于阿片类药物成瘾治疗的美沙酮、丁丙诺啡和丁丙诺啡联合纳洛酮的数据。这些药物的使用数据也从以色列卫生部药品管理司维护的数据库中提取。这些数据被转换为定义的日剂量(DDD)/1000 居民/日:自2013年以来,接受药物辅助治疗的患者人数增加了10%,在政府运营的中心中,患者从单纯使用丁丙诺啡转变为使用丁丙诺啡/纳洛酮。美沙酮仍然是最受欢迎的维持治疗药物:结论:阿片类药物维持治疗处方的变化与阿片类药物消费量的大幅增长并不匹配。可以通过建立综合数据库、医疗机构与政府之间的合作以及进一步发展非污名化和无障碍服务来优化治疗。
{"title":"Changes and trends in medication-assisted treatment in Israel.","authors":"Adi Marom, Iris Levy, Paola Rosca","doi":"10.1186/s13584-022-00551-8","DOIUrl":"10.1186/s13584-022-00551-8","url":null,"abstract":"<p><strong>Background: </strong>As opioid prescription in Israel is increasing, there is a growing need for monitoring opioid use disorder and providing opioid agonist therapy. Our goal is to describe, sub-analyze, and identify obstacles in the treatment of opioid misuse in the Israeli medication assisted treatment centers.</p><p><strong>Methods: </strong>Data on methadone, buprenorphine, and buprenorphine combined with naloxone for the indication of opioid addiction treatment for the period 2013-2020 were obtained from pharmaceutical companies that distribute them in Israel. Data on utilization of these drugs were also extracted from the database maintained by the Israel Ministry of Health's Pharmaceutical Administration Division. The data were converted to defined daily doses (DDD)/1000 inhabitants/day.</p><p><strong>Results: </strong>The number of patients receiving medication assisted treatment increased by 10% since 2013, with a shift from buprenorphine alone to buprenorphine/naloxone in government-run centers. Methadone remains the most popular maintenance drug.</p><p><strong>Conclusions: </strong>The change in opioid maintenance prescription does not match the significant increase in opioid consumption. Optimization of treatment can be achieved by the creation of a comprehensive database, cooperation between healthcare organizations and the government and further development of non-stigmatic and accessible services.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"12 1","pages":"1"},"PeriodicalIF":3.5,"publicationDate":"2023-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9826022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Politics of reproduction: a view from Israel on the Dobbs decision. 生殖政治:以色列对多布斯案判决的看法。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-01-24 DOI: 10.1186/s13584-022-00550-9
Carmel Shalev

Background: This opinion piece looks at the recent decision of the United States Supreme Court in Dobbs v. Jackson Women's Health Organization and then compares the law on abortion in the USA to the law in Israel on reproductive medicine in general. The Dobbs decision validated a Mississippi state law that restricted access to abortion, while overruling the landmark precedent of Roe v. Wade on women's constitutional right to safe abortion. It declared that the US constitution does not confer upon women any right to abortion, whether pre- or post-viability, sending shockwaves throughout the world. It also had an immediate effect on women's reproductive health in the US.

Main body: Women's right to reproductive freedom and to make decisions about their lives and their bodies is key to their hard-won equality. Still, abortion remains in ongoing controversy worldwide with legal barriers that impact upon the most vulnerable. In Israel, abortion is relatively available, accessible, affordable, and acceptable, in both law and practice. This is because of the lenient and nuanced stance of rabbinical authorities in the Jewish law tradition. This stance, together with Israel's post-Holocaust biblical culture of "be fruitful and multiply", also underlies its high rates of medically assisted reproduction for the treatment of infertility, including preimplantation genetic diagnosis of fertilized eggs. Women's bodies mediate all these repro-genetic technologies, in most cases for the benefit of others, not because of their own health needs. There is also concern about global practices and market forces that objectify women's bodies, exploit women and are harmful to their health, wellbeing, and dignity, carrying on outdated patriarchal patterns.

Conclusion: Reproductive health policy ought to be based on an ethic of care and responsibility first and foremost for the women, as well as the children they choose to bring to life, in the spirit of the Jewish tradition that her life is of greater value than the fetus'. Women deserve control of their bodies and their lives and respect for the choices they make to the best of their judgment, which when it comes to abortion are mostly hard ones. They have a right to reproductive choice, freedom, autonomy, and dignity. The views expressed in this perspective are those of the author.

背景:这篇评论文章着眼于最近美国最高法院在多布斯诉杰克逊妇女健康组织案中的判决,然后将美国的堕胎法与以色列的一般生殖医学法律进行比较。多布斯案的判决证实了密西西比州一项限制堕胎的法律,同时推翻了罗伊诉韦德案(Roe v. Wade)关于妇女安全堕胎的宪法权利的具有里程碑意义的先例。它宣布,美国宪法不赋予妇女任何堕胎权利,无论是在怀孕前还是怀孕后,这在全世界引起了冲击波。它还对美国妇女的生殖健康产生了直接影响。主体:妇女享有生育自由和对自己的生活和身体作出决定的权利,是她们来之不易的平等的关键。尽管如此,堕胎在世界范围内仍然存在争议,法律障碍影响着最脆弱的群体。在以色列,无论是在法律上还是在实践中,堕胎都是相对可行的、可获得的、负担得起的和可接受的。这是因为犹太律法传统中拉比权威的宽容和微妙的立场。这一立场,加上以色列大屠杀后的圣经文化"生养众多",也是其医疗辅助生殖治疗不孕症的高比率的基础,包括对受精卵进行植入前遗传学诊断。妇女的身体调节所有这些生殖遗传技术,在大多数情况下是为了他人的利益,而不是因为她们自己的健康需要。还令人关切的是,全球的做法和市场力量将妇女的身体物化,剥削妇女,损害她们的健康、福祉和尊严,延续了过时的父权模式。结论:生殖健康政策的基础应该是首先对妇女及其选择生育的孩子负责的伦理道德,本着妇女的生命比胎儿的生命更有价值的犹太传统精神。女性有权控制自己的身体和生活,有权尊重她们做出的最好的选择,当涉及到堕胎时,这些选择大多是艰难的。她们有生育选择、自由、自主和尊严的权利。这一观点仅代表作者的观点。
{"title":"Politics of reproduction: a view from Israel on the Dobbs decision.","authors":"Carmel Shalev","doi":"10.1186/s13584-022-00550-9","DOIUrl":"https://doi.org/10.1186/s13584-022-00550-9","url":null,"abstract":"<p><strong>Background: </strong>This opinion piece looks at the recent decision of the United States Supreme Court in Dobbs v. Jackson Women's Health Organization and then compares the law on abortion in the USA to the law in Israel on reproductive medicine in general. The Dobbs decision validated a Mississippi state law that restricted access to abortion, while overruling the landmark precedent of Roe v. Wade on women's constitutional right to safe abortion. It declared that the US constitution does not confer upon women any right to abortion, whether pre- or post-viability, sending shockwaves throughout the world. It also had an immediate effect on women's reproductive health in the US.</p><p><strong>Main body: </strong>Women's right to reproductive freedom and to make decisions about their lives and their bodies is key to their hard-won equality. Still, abortion remains in ongoing controversy worldwide with legal barriers that impact upon the most vulnerable. In Israel, abortion is relatively available, accessible, affordable, and acceptable, in both law and practice. This is because of the lenient and nuanced stance of rabbinical authorities in the Jewish law tradition. This stance, together with Israel's post-Holocaust biblical culture of \"be fruitful and multiply\", also underlies its high rates of medically assisted reproduction for the treatment of infertility, including preimplantation genetic diagnosis of fertilized eggs. Women's bodies mediate all these repro-genetic technologies, in most cases for the benefit of others, not because of their own health needs. There is also concern about global practices and market forces that objectify women's bodies, exploit women and are harmful to their health, wellbeing, and dignity, carrying on outdated patriarchal patterns.</p><p><strong>Conclusion: </strong>Reproductive health policy ought to be based on an ethic of care and responsibility first and foremost for the women, as well as the children they choose to bring to life, in the spirit of the Jewish tradition that her life is of greater value than the fetus'. Women deserve control of their bodies and their lives and respect for the choices they make to the best of their judgment, which when it comes to abortion are mostly hard ones. They have a right to reproductive choice, freedom, autonomy, and dignity. The views expressed in this perspective are those of the author.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"12 1","pages":"3"},"PeriodicalIF":4.5,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines. 以色列研究人员在有关 COVID-19 疫苗的科学文献中的作用。
IF 3.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2022-11-23 DOI: 10.1186/s13584-022-00548-3
Bruce Rosen, Nadav Davidovitch, Gabriel Chodick, Avi Israeli

Background: The accurate and timely publication of scientific findings is a key component of the global response to the COVID-19 pandemic. This article explores the role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.

Methods: Content and bibliometric analysis of articles included in the Web of Science database regarding COVID-19 vaccines, that were published between January 2020 and June 2022.

Results: The Web of Science includes 18,596 articles regarding COVID-19 vaccines that were published between January 2020 and June 2022. 536 (3%) of those articles had at least one Israeli author. These "Israeli articles" accounted for 11% of the NEJM articles on COVID-19 vaccines, 9% of such articles in Nature Medicine, and 4% of such articles in the Lancet. 80 of the 536 Israeli articles (15%) were recognized as "Highly Cited Papers" (articles that rank in the top 1% by citations for field and publication year). Most of the Israeli Highly Cited Papers (HCPs) analyzed the safety and/or efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech (BNT162b2). Most of the Israeli HCPs made use of detailed and comprehensive individual data available from Israel's health plans, hospitals, or Ministry of Health. The 15% HCP rate (i.e., the number of HCPs divided by the number of all articles) for the Israeli articles was triple the HCP rate for all articles on COVID-19 vaccines (5%). A key factor contributing to Israel's prominent role in rapid publication of vaccination impact studies was Israel's being a world leader in the initial vaccination rollout, the administration of boosters, and the vaccination of pregnant women. Other contributing factors include Israeli researchers' access to well-developed electronic health record systems linking vaccinations and outcomes, the analytic strengths of leading Israeli researchers and research institutions, collaborations with leading research institutions in other countries, and the ability to quickly identify emerging research opportunities and mobilize accordingly. Recent developments in the priorities and selection criteria of leading journals have also played a role; these include an increased openness to well-designed observational studies and to manuscripts from outside of Europe and North America.

Conclusions: Israeli researchers, Israeli research institutions, and the Israeli government can, and should, take concrete steps to build upon lessons learned in the course of the recent surge of high-quality publications related to COVID-19 vaccines (such as the value of linking data across organizations). These lessons can be applied to a wide range of fields, including fields that go well beyond vaccines and pandemic responses.

背景:准确及时地发表科学发现是全球应对 COVID-19 大流行的关键组成部分。本文探讨了以色列研究人员在有关 COVID-19 疫苗的科学文献中所扮演的角色:对 Web of Science 数据库收录的 2020 年 1 月至 2022 年 6 月间发表的有关 COVID-19 疫苗的文章进行内容和文献计量分析:结果:Web of Science收录了2020年1月至2022年6月期间发表的18596篇有关COVID-19疫苗的文章。其中 536 篇文章(3%)至少有一名以色列作者。这些 "以色列文章 "占《NEJM》有关 COVID-19 疫苗文章的 11%,占《自然医学》此类文章的 9%,占《柳叶刀》此类文章的 4%。在 536 篇以色列文章中,有 80 篇(15%)被评为 "高被引论文"(按领域和发表年份计算,被引次数排名前 1%的文章)。大多数以色列高被引论文 (HCP) 分析了辉瑞公司和 BioNTech 公司开发的 COVID-19 疫苗 (BNT162b2) 的安全性和/或有效性。大多数以色列 HCP 都使用了以色列医疗计划、医院或卫生部提供的详细而全面的个人数据。以色列文章中 15%的 HCP 率(即 HCP 数量除以所有文章数量)是 COVID-19 疫苗所有文章中 HCP 率(5%)的三倍。以色列在快速发表疫苗接种影响研究方面发挥了突出作用,一个关键因素是以色列在最初疫苗接种推广、强化免疫接种和孕妇疫苗接种方面处于世界领先地位。其他促成因素包括:以色列研究人员可以使用发达的电子健康记录系统,将疫苗接种和结果联系起来;以色列主要研究人员和研究机构的分析实力;与其他国家主要研究机构的合作;以及快速识别新出现的研究机会并进行相应动员的能力。主要期刊的优先级和选择标准的最新发展也起到了一定作用;其中包括对设计良好的观察性研究以及欧洲和北美以外的稿件更加开放:以色列研究人员、以色列研究机构和以色列政府可以而且应该采取具体步骤,借鉴最近与 COVID-19 疫苗相关的高质量论文激增过程中汲取的经验教训(如跨机构数据链接的价值)。这些经验教训可应用于广泛的领域,包括疫苗和大流行病应对措施以外的领域。
{"title":"The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.","authors":"Bruce Rosen, Nadav Davidovitch, Gabriel Chodick, Avi Israeli","doi":"10.1186/s13584-022-00548-3","DOIUrl":"10.1186/s13584-022-00548-3","url":null,"abstract":"<p><strong>Background: </strong>The accurate and timely publication of scientific findings is a key component of the global response to the COVID-19 pandemic. This article explores the role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.</p><p><strong>Methods: </strong>Content and bibliometric analysis of articles included in the Web of Science database regarding COVID-19 vaccines, that were published between January 2020 and June 2022.</p><p><strong>Results: </strong>The Web of Science includes 18,596 articles regarding COVID-19 vaccines that were published between January 2020 and June 2022. 536 (3%) of those articles had at least one Israeli author. These \"Israeli articles\" accounted for 11% of the NEJM articles on COVID-19 vaccines, 9% of such articles in Nature Medicine, and 4% of such articles in the Lancet. 80 of the 536 Israeli articles (15%) were recognized as \"Highly Cited Papers\" (articles that rank in the top 1% by citations for field and publication year). Most of the Israeli Highly Cited Papers (HCPs) analyzed the safety and/or efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech (BNT162b2). Most of the Israeli HCPs made use of detailed and comprehensive individual data available from Israel's health plans, hospitals, or Ministry of Health. The 15% HCP rate (i.e., the number of HCPs divided by the number of all articles) for the Israeli articles was triple the HCP rate for all articles on COVID-19 vaccines (5%). A key factor contributing to Israel's prominent role in rapid publication of vaccination impact studies was Israel's being a world leader in the initial vaccination rollout, the administration of boosters, and the vaccination of pregnant women. Other contributing factors include Israeli researchers' access to well-developed electronic health record systems linking vaccinations and outcomes, the analytic strengths of leading Israeli researchers and research institutions, collaborations with leading research institutions in other countries, and the ability to quickly identify emerging research opportunities and mobilize accordingly. Recent developments in the priorities and selection criteria of leading journals have also played a role; these include an increased openness to well-designed observational studies and to manuscripts from outside of Europe and North America.</p><p><strong>Conclusions: </strong>Israeli researchers, Israeli research institutions, and the Israeli government can, and should, take concrete steps to build upon lessons learned in the course of the recent surge of high-quality publications related to COVID-19 vaccines (such as the value of linking data across organizations). These lessons can be applied to a wide range of fields, including fields that go well beyond vaccines and pandemic responses.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"11 1","pages":"39"},"PeriodicalIF":3.5,"publicationDate":"2022-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
People with serious mental illness are at higher risk for acute care hospitalization in Israel, 2000-2019. 2000-2019年,在以色列,患有严重精神疾病的人接受急诊住院治疗的风险更高。
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2022-09-08 DOI: 10.1186/s13584-022-00544-7
Ethel-Sherry Gordon, Rinat Yoffe, Nehama Frimit Goldberger, Jill Meron, Ziona Haklai

Background: People with severe mental disorders have higher mortality rates and more chronic physical conditions than the general population. Recent reforms in the Israeli mental health system included reducing the number of psychiatric hospital beds ("Structural Reform"), establishing community- based rehabilitation services ("Rehabilitation Reform"), and the transfer of governmental responsibility to the Health Maintenance Organizations (HMOs) ("Insurance Reform"). We examined how these changes have impacted the physical health of people with severe mental illness as reflected in acute care hospitalizations.

Methods: Data from the National Psychiatric Case Register were linked with data from the National Hospital Discharges Database for 2000-2019. Acute care discharges from public hospitals were identified for people who had a psychiatric hospitalization with a diagnosis of severe mental illness (SMI, ICD-10 codes F10-F69 or F90-F99) within the preceding 5 years. The discharge rate of SMI patients was compared to that of the total population by age, diagnosis group, and period of hospitalization. Total and age-standardized discharge ratios (SDR) were calculated, using indirect standardization.

Results: The SDR for total acute care hospitalizations showed that discharge rates in 2016-2019 were 2.7 times higher for the SMI population than expected from the total population. The highest SDR was for external causes (5.7), followed by respiratory diseases (4.4), infectious diseases (3.9), skin diseases (3.7) and diabetes (3.3). The lowest SDR was for cancer (1.6). The total discharge rate ratio was lowest at ages 65-74 (2.2) and highest at ages 45-54 (3.2). The SDR was lowest for females at ages 25-34 (2.1) and for males at ages 18-24 (2.3). SDRs increased over the study period for all diagnoses. This increasing trend slowed at the end of the period, and between 2012-2015 and 2016-2019 there was a small decrease for skin and liver diseases, the SDR was stable for cancer and the increase was smaller for respiratory, infectious and circulatory diseases and diabetes.

Conclusion: This study showed higher hospitalization rates in people with SMI compared to the total population. These differences increased between 2000 and 2019 following the opening of alternative services in the community, possibly due to a higher likelihood of psychiatric hospitalization only for those with more severe mental disease. We recommend that general practitioners and mental health professionals in the community be made aware of the essential importance of good physical healthcare, and collaborate on health promotion and disease prevention in the SMI population.

背景:与一般人群相比,患有严重精神障碍的人有更高的死亡率和更多的慢性身体疾病。以色列精神卫生系统最近的改革包括减少精神病医院病床的数量(“结构改革”),建立以社区为基础的康复服务(“康复改革”),以及将政府责任移交给健康维护组织(“保险改革”)。我们研究了这些变化是如何影响严重精神疾病患者的身体健康的,反映在急性护理住院治疗中。方法:将来自国家精神病学病例登记册的数据与2000-2019年国家医院出院数据库的数据相关联。在过去5年内,诊断为严重精神疾病(SMI, ICD-10代码F10-F69或F90-F99)的精神病住院患者被确定为公立医院的急性护理出院。按年龄、诊断组、住院时间对重度精神分裂症患者的出院率与总人口的出院率进行比较。采用间接标准化计算总放电比和年龄标准化放电比(SDR)。结果:2016-2019年,急性护理住院总人数的SDR显示,重度精神障碍人群的出院率是总人口预期的2.7倍。最高的SDR是外因(5.7),其次是呼吸系统疾病(4.4)、传染病(3.9)、皮肤病(3.7)和糖尿病(3.3)。最低的SDR是癌症(1.6)。总出院率比以65 ~ 74岁最低(2.2),45 ~ 54岁最高(3.2)。25-34岁女性的SDR最低(2.1),18-24岁男性最低(2.3)。在整个研究期间,所有诊断的sdr都有所增加。在2012-2015年至2016-2019年期间,皮肤和肝脏疾病的SDR略有下降,癌症的SDR保持稳定,呼吸系统、传染病和循环系统疾病以及糖尿病的SDR增幅较小。结论:本研究显示重度精神分裂症患者的住院率高于总人口。在2000年至2019年期间,在社区开放替代服务之后,这些差异有所增加,可能是由于只有患有更严重精神疾病的人才更有可能住院治疗。我们建议让社区的全科医生和精神卫生专业人员意识到良好身体保健的重要性,并在重度精神障碍人群中开展健康促进和疾病预防方面的合作。
{"title":"People with serious mental illness are at higher risk for acute care hospitalization in Israel, 2000-2019.","authors":"Ethel-Sherry Gordon,&nbsp;Rinat Yoffe,&nbsp;Nehama Frimit Goldberger,&nbsp;Jill Meron,&nbsp;Ziona Haklai","doi":"10.1186/s13584-022-00544-7","DOIUrl":"https://doi.org/10.1186/s13584-022-00544-7","url":null,"abstract":"<p><strong>Background: </strong>People with severe mental disorders have higher mortality rates and more chronic physical conditions than the general population. Recent reforms in the Israeli mental health system included reducing the number of psychiatric hospital beds (\"Structural Reform\"), establishing community- based rehabilitation services (\"Rehabilitation Reform\"), and the transfer of governmental responsibility to the Health Maintenance Organizations (HMOs) (\"Insurance Reform\"). We examined how these changes have impacted the physical health of people with severe mental illness as reflected in acute care hospitalizations.</p><p><strong>Methods: </strong>Data from the National Psychiatric Case Register were linked with data from the National Hospital Discharges Database for 2000-2019. Acute care discharges from public hospitals were identified for people who had a psychiatric hospitalization with a diagnosis of severe mental illness (SMI, ICD-10 codes F10-F69 or F90-F99) within the preceding 5 years. The discharge rate of SMI patients was compared to that of the total population by age, diagnosis group, and period of hospitalization. Total and age-standardized discharge ratios (SDR) were calculated, using indirect standardization.</p><p><strong>Results: </strong>The SDR for total acute care hospitalizations showed that discharge rates in 2016-2019 were 2.7 times higher for the SMI population than expected from the total population. The highest SDR was for external causes (5.7), followed by respiratory diseases (4.4), infectious diseases (3.9), skin diseases (3.7) and diabetes (3.3). The lowest SDR was for cancer (1.6). The total discharge rate ratio was lowest at ages 65-74 (2.2) and highest at ages 45-54 (3.2). The SDR was lowest for females at ages 25-34 (2.1) and for males at ages 18-24 (2.3). SDRs increased over the study period for all diagnoses. This increasing trend slowed at the end of the period, and between 2012-2015 and 2016-2019 there was a small decrease for skin and liver diseases, the SDR was stable for cancer and the increase was smaller for respiratory, infectious and circulatory diseases and diabetes.</p><p><strong>Conclusion: </strong>This study showed higher hospitalization rates in people with SMI compared to the total population. These differences increased between 2000 and 2019 following the opening of alternative services in the community, possibly due to a higher likelihood of psychiatric hospitalization only for those with more severe mental disease. We recommend that general practitioners and mental health professionals in the community be made aware of the essential importance of good physical healthcare, and collaborate on health promotion and disease prevention in the SMI population.</p>","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":"11 1","pages":"32"},"PeriodicalIF":4.5,"publicationDate":"2022-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461173/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10632596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine-learning based routing of callers in an Israeli mental health hotline 以色列心理健康热线中基于机器学习的呼叫路由
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2022-06-03 DOI: 10.1186/s13584-022-00534-9
Akiva Kleinerman, Ariel Rosenfeld, Hanan Rosemarin
{"title":"Machine-learning based routing of callers in an Israeli mental health hotline","authors":"Akiva Kleinerman, Ariel Rosenfeld, Hanan Rosemarin","doi":"10.1186/s13584-022-00534-9","DOIUrl":"https://doi.org/10.1186/s13584-022-00534-9","url":null,"abstract":"","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43135942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Party keepers: a significant community-based intervention for harm reduction 政党守护者:减少伤害的重要社区干预
IF 4.5 4区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2022-06-03 DOI: 10.1186/s13584-022-00535-8
R. Zucker, Z. Mor, Anuar Abudin, Glen E. Davis, Hansel Arroyo, Gal Wagner Kolasko, Dan Arad, Guy Shilo
{"title":"Party keepers: a significant community-based intervention for harm reduction","authors":"R. Zucker, Z. Mor, Anuar Abudin, Glen E. Davis, Hansel Arroyo, Gal Wagner Kolasko, Dan Arad, Guy Shilo","doi":"10.1186/s13584-022-00535-8","DOIUrl":"https://doi.org/10.1186/s13584-022-00535-8","url":null,"abstract":"","PeriodicalId":46694,"journal":{"name":"Israel Journal of Health Policy Research","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48078693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Israel Journal of Health Policy Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1